Culture Biosciences
PrivateLast Round
Series C
Dec 16, 2025
Est. Valuation
$1.71M
Total Funding Raised
$100.62M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Culture Biosciences is a biotechnology company that develops automated bioreactors and cloud-native software to optimize manufacturing processes for sensitive cell cultures and high cell density fermentation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Culture Biosciences Comparables
Compare Culture Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mytos | 79% | |
| QB Systems | 78% | |
| Donaldson Company | 77% |
Culture Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 16, 2025 | ||||
| Series B | Oct 14, 2021 | ||||
| Series A | Mar 4, 2020 | ||||
| Seed | Feb 12, 2019 | ||||
| Accelerator | Jan 1, 2018 |
Culture Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A, Series B, Series C, Seed |
| Refactor Capital | Seed |
| The Production Board | Series A, Series B |
| Synthesis Capital | Series B, Series C |
| Cultivian Sandbox Ventures | Series B, Series C, Series A |
| Craft Ventures | Series B |
| Northpond Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 36% MoM.
- Apr 14, 2026
Mike Stapleton appointed to the Board of Directors.
Recent news
Latest coverage and updates
- attends_eventJul 7, 2026
Culture Biosciences attended event NIMBL meeting on Jul 1st '26.
Culture Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Culture Biosciences's valuation, stock price, and market status.
Is Culture Biosciences a public or private company?
Culture Biosciences is a private company.
What is the current stock price of Culture Biosciences?
Culture Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Culture Biosciences worth (valuation)?
Culture Biosciences's valuation is estimated at $1.7M based on funding round data.
Can I buy Culture Biosciences stock?
Culture Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Culture Biosciences's last funding round?
Culture Biosciences's most recent funding round was Series C on January 1, 2018.
Who are the main investors in Culture Biosciences?
Key investors in Culture Biosciences include S32, Cultivian Sandbox Ventures, Y Combinator, Northpond Ventures, Sandbox Industries.
Will Culture Biosciences IPO soon?
No public IPO plans have been announced for Culture Biosciences.
How can I track Culture Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Culture Biosciences's secondary market activity and sign up for updates.